DOCNEUTRAL

Return on Equity (ROE)

2.8%

Updated 53h ago

Sector Performance

17th percentile

DOC

2.8%

Sector Median

13.8%

Sector Avg

31.4%

📊

Deep Analysis

Return on equity (ROE) measures how efficiently a company generates profit from every dollar of shareholders' equity; a 2.8% ROE means DOC earns $0.028 for each $1 of equity.

This is far below the sector median of 13.9%, placing DOC in the 15th percentile among its peers — meaning 85% of similar companies deliver a higher return. No trend data is available because the year-over-year change is N/A, the quarter-over-quarter change is N/A, and only one historical value (2.8%) is provided. A single low ROE with no trend to assess leaves an investor unable to determine whether the metric is deteriorating or improving, creating uncertainty rather than a clear risk or opportunity signal. This low absolute level and poor relative rank suggest the company is underperforming its peers in generating shareholder value, which is a concern. The NEUTRAL overall verdict is supported by this metric: the weak ROE indicates downside risk, but the lack of trend data prevents a stronger bearish stance.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about DOC?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are DOC's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.